Miro Health files patent, positioning company to lead the charge on neurological phenotyping

Today, Miro Health filed a patent for the virtual identity verification tool for use in clinical trials. Virtual identity verification is required to expand clinical study participation beyond an institutional setting. To date, researchers have been constrained by in-person verification, limiting the geographic region of candidates and the number of participants.


Miro’s HIPAA and FDA compliant tool supports the a-synchronous identity confirmation of remote candidates, paving the way for scalable participation and the delivery of precision phenotypes that can accurately characterize participant data for large-scale studies.

Recent Posts

See All

Solving the neurological puzzle of COVID-19

Miro Health and Johns Hopkins have teamed up to investigate how COVID-19 affects the brain. Doctors on the frontlines of COVID-19 have been reporting unusual symptoms ranging from loss of smell and ne

  • Frame 25
  • Frame 26
  • Frame 35
appstore-aaf345f67a67888a4c00c42b1f5d759

COMPANY

PRODUCT

QUESTIONS